Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Obeticholic Acid in Moderately Severe Alcoholic Hepatitis
NCT02039219Phase 2Terminated
- Start
- Nov 2014
- Primary completion
- Jul 2017
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of obeticholic acid in alcoholic hepatitis (AH). Started Nov 2014; status: terminated.
02
Drugs
obeticholic acid
03
Conditions
alcoholic hepatitis (AH)
Beyond the preview
Go deeper on NCT02039219.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02039219.